Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Makers Laboratories's Total Assets for the quarter that ended in Mar. 2026 was ₹1,666 Mil.
During the past 12 months, Makers Laboratories's average Total Assets Growth Rate was 4.80% per year.
During the past 3 years, the average Total Assets Growth Rate was 1.40% per year.
During the past 5 years, the average Total Assets Growth Rate was 3.40% per year.
During the past 10 years, the average Total Assets Growth Rate was 16.60% per year.
During the past 13 years, Makers Laboratories's highest 3-Year average Total Assets Growth Rate was 35.70%. The lowest was 1.20%. And the median was 9.00%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Makers Laboratories's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Makers Laboratories Total Assets Related Terms
Makers Laboratories Total Assets Historical Data
* Premium members only.
The historical data trend for Makers Laboratories's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Makers Laboratories's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Makers Laboratories (BOM:506919) has a Total Assets of ₹1,666 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Makers Laboratories and its competitors.
Is Makers Laboratories' Total Assets too high?
Makers Laboratories' current Total Assets is ₹1,666 Mil. Overall, Makers Laboratories has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Makers Laboratories' Total Assets compare to ZTS?
Makers Laboratories' Total Assets of ₹1,666 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Makers Laboratories and its competitors. Makers Laboratories's current Total Assets is ₹1,666 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Makers Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Makers Laboratories (BOM:506919) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹174.67, compared to a current price of ₹151.50 — trading 13.3% below its estimated fair value. The current Total Assets is ₹1,666 Mil. Makers Laboratories' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Makers Laboratories (BOM:506919), the current Total Assets is ₹1,666 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Makers Laboratories (BOM:506919) Overvalued in 2026?
Based on GuruFocus' analysis, Makers Laboratories stock appears to be undervalued.
The current stock price of ₹151.50 is trading 13.3% below its estimated GF Value™ of ₹174.67.
GuruFocus considers Makers Laboratories to be Modestly Undervalued.
Key valuation signals for BOM:506919:
Total Assets: ₹1,666 Mil
GF Value™: ₹174.67 vs. price of ₹151.50 (13.3% below fair value)
No single metric tells the full story. See the BOM:506919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough Range), and Exylin (Amoxycillin range), among others. The reportable segment of the company is the Pharmaceutical segment.
68GF Score
Get the complete analysis for BOM:506919
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506919 has been successfully added to your 
